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Background: Galectin-3 (gal-3), a β-galactoside-binding lectin macrophage product, is upregulated in models of hypertrophy before onset of 
frank heart failure (HF), promotes myocardial fibrosis and may play a role in LV remodeling. The relationship between gal-3 and cardiac structure in 
patients with acute dyspnea and the impact of gal-3 on long-term mortality in patients with known echocardiographic indices is unknown.
Methods: 115 patients presenting to the emergency department with acute dyspnea who had gal-3 levels and detailed echocardiographic studies 
on admission were studied. Regression analysis was used to identify echocardiographic and clinical correlates of gal-3.
Results: In the overall cohort of patients with acute dyspnea (N = 115), higher gal-3 levels were associated with older age (r = 0.26, P = .006), 
lower creatinine clearance (r = -0.42, P < .001), a higher blood urea nitrogen (r = 0.38, P < .001), and higher levels of N-terminal-proBNP (r = 0.39, 
P < .001) or C-reactive protein (r = 0.26, P = .005). Higher gal-3 levels were associated with tissue Doppler E/Ea ratio (r = 0.35, P = .01), lower 
tissue Doppler E wave velocity (r = -0.25, P = .03), a lower right ventricular fractional area change (r = -0.19, P = .05), higher RV systolic pressure (r 
= 0.37, P < .001), and more severe mitral (r = 0.30, P = .001) or tricuspid regurgitation (r = 0.26, P = .005). In the subgroup of patients diagnosed 
with acutely destabilized HF, the association between gal-3 and valvular regurgitation and RV systolic pressure persisted. In a multivariate Cox 
regression model including echocardiographic markers traditionally associated with poorer outcomes, gal-3 remained a significant, independent 
predictor of 4-year mortality (for the highest quartile of gal-3, HR = 14.29, 95% confidence interval 11.5-2196.2; P < .001).
Conclusions: Among dyspneic patients with and without acute HF, gal-3 levels are associated with echocardiographic markers of LV filling 
pressures, LV diastolic function, and RV function. In patients with acute HF, a single admission gal-3 level predicts mortality to four years, 
independent of other traditional echocardiographic markers of risk.
